Macquarie Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,799,420
| Closed | -$5.2M | – | 2421 |
|
|
2020
Q1 | $5.2M | Sell |
1,799,420
-367,996
| -17% | -$1.06M | 0.01% | 706 |
|
|
2019
Q4 | $8.22M | Sell |
2,167,416
-93,262
| -4% | -$353K | 0.01% | 685 |
|
|
2019
Q3 | $11.6M | Sell |
2,260,678
-151,480
| -6% | -$775K | 0.02% | 575 |
|
|
2019
Q2 | $15M | Sell |
2,412,158
-209,542
| -8% | -$1.3M | 0.03% | 527 |
|
|
2019
Q1 | $18.6M | Sell |
2,621,700
-86,517
| -3% | -$615K | 0.03% | 478 |
|
|
2018
Q4 | $23.1M | Buy |
2,708,217
+923,099
| +52% | +$7.88M | 0.04% | 392 |
|
|
2018
Q3 | $35.7M | Buy |
1,785,118
+474,808
| +36% | +$9.51M | 0.06% | 345 |
|
|
2018
Q2 | $33.8M | Buy |
1,310,310
+145,412
| +12% | +$3.76M | 0.06% | 356 |
|
|
2018
Q1 | $27.8M | Buy |
1,164,898
+273,936
| +31% | +$6.55M | 0.05% | 387 |
|
|
2017
Q4 | $30.2M | Buy |
890,962
+139,934
| +19% | +$4.74M | 0.05% | 370 |
|
|
2017
Q3 | $15.9M | Buy |
+751,028
| New | +$15.9M | 0.03% | 502 |
|